- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5551
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Data mining for mutation-specific targets in acute myeloid leukemia ; day:6 ; month:2 ; year:2019 ; pages:1-18
Leukemia ; (6.2.2019), 1-18
- Urheber
-
Benard, Brooks
Gentles, Andrew J.
Köhnke, Thomas
Majeti, Ravindra
Thomas, Daniel
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41375-019-0387-y
- URN
-
urn:nbn:de:101:1-2019031121355655577624
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Benard, Brooks
- Gentles, Andrew J.
- Köhnke, Thomas
- Majeti, Ravindra
- Thomas, Daniel
- SpringerLink (Online service)
Ähnliche Objekte (12)
Novel Therapeutic Targets in Acute Myeloid Leukemia (AML)
Recurrent SETD2 mutation in NPM1-mutated acute myeloid leukemia
RhoA: A therapeutic target for chronic myeloid leukemia
Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation
Quantitative detection of DNMT3A R882H mutation in acute myeloid leukemia
The clinical impact of IKZF1 mutation in acute myeloid leukemia
Identification of a novel NPM1 mutation in acute myeloid leukemia
Mitochondrial metabolism as a target for acute myeloid leukemia treatment
Glutamine synthetase : a potential therapeutic target in acute myeloid leukemia
The specific distribution pattern of IKZF1 mutation in acute myeloid leukemia
TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome
Genetic and nano-therapeutic interventions to understand and target myeloid leukemia
Novel Therapeutic Targets in Acute Myeloid Leukemia (AML)
Recurrent SETD2 mutation in NPM1-mutated acute myeloid leukemia
RhoA: A therapeutic target for chronic myeloid leukemia
Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation
Quantitative detection of DNMT3A R882H mutation in acute myeloid leukemia
The clinical impact of IKZF1 mutation in acute myeloid leukemia
Identification of a novel NPM1 mutation in acute myeloid leukemia
Mitochondrial metabolism as a target for acute myeloid leukemia treatment
Glutamine synthetase : a potential therapeutic target in acute myeloid leukemia
The specific distribution pattern of IKZF1 mutation in acute myeloid leukemia
TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome
Genetic and nano-therapeutic interventions to understand and target myeloid leukemia
Novel Therapeutic Targets in Acute Myeloid Leukemia (AML)
Recurrent SETD2 mutation in NPM1-mutated acute myeloid leukemia
RhoA: A therapeutic target for chronic myeloid leukemia
Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation
Quantitative detection of DNMT3A R882H mutation in acute myeloid leukemia
The clinical impact of IKZF1 mutation in acute myeloid leukemia
Identification of a novel NPM1 mutation in acute myeloid leukemia
Mitochondrial metabolism as a target for acute myeloid leukemia treatment
Glutamine synthetase : a potential therapeutic target in acute myeloid leukemia
The specific distribution pattern of IKZF1 mutation in acute myeloid leukemia
TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome